Cargando…

Aggresome–Autophagy Associated Gene HDAC6 Is a Potential Biomarker in Pan-Cancer, Especially in Colon Adenocarcinoma

BACKGROUND: Histone deacetylase 6 (HDAC6) regulates cytoplasmic signaling networks through the deacetylation of various cytoplasmic substrates. Recent studies have identified the role of HDAC6 in tumor development and immune metabolism, but its specific function remains unclear. METHODS: The current...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhiyong, Zhang, Xin, Huang, Aimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416150/ https://www.ncbi.nlm.nih.gov/pubmed/34485153 http://dx.doi.org/10.3389/fonc.2021.718589

Ejemplares similares

Aggresome formation is regulated by RanBPM through an interaction with HDAC6
por: Salemi, Louisa M., et al.
Publicado: (2014)

HDAC6/aggresome processing pathway importance for inflammasome formation is context dependent
por: Wang, Longlong, et al.
Publicado: (2023)

Both p62/SQSTM1-HDAC6-dependent autophagy and the aggresome pathway mediate CDK1 degradation in human breast cancer
por: Galindo-Moreno, María, et al.
Publicado: (2017)

Analysis of HDAC6 and BAG3-Aggresome Pathways in African Swine Fever Viral Factory Formation
por: Muñoz-Moreno, Raquel, et al.
Publicado: (2015)

DEF6 has potential to be a biomarker for cancer prognosis: A pan-cancer analysis
por: Yuan, Ziming, et al.
Publicado: (2023)

Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6
por: Olzmann, James A., et al.
Publicado: (2007)

Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression
por: Chen, Xi, et al.
Publicado: (2022)

An Integrated Pan-Cancer Analysis of ADAMTS12 and Its Potential Implications in Pancreatic Adenocarcinoma
por: Song, Caiyun, et al.
Publicado: (2022)

Autophagy Modulation in Aggresome Formation: Emerging Implications and Treatments of Alzheimer’s Disease
por: Rahman, Md. Ataur, et al.
Publicado: (2022)

The E3-Ubiquitin Ligase TRIM50 Interacts with HDAC6 and p62, and Promotes the Sequestration and Clearance of Ubiquitinated Proteins into the Aggresome
por: Fusco, Carmela, et al.
Publicado: (2012)

Characterizing HDAC Pathway Copy Number Variation in Pan-Cancer
por: Yang, Shuming, et al.
Publicado: (2022)

FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
por: Cai, Jiayang, et al.
Publicado: (2022)

Distal Renal Tubules Are Deficient in Aggresome Formation and Autophagy upon Aldosterone Administration
por: Cheema, Muhammad Umar, et al.
Publicado: (2014)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

Accumulation of Endogenous LITAF in Aggresomes
por: Eaton, Heather E., et al.
Publicado: (2012)

N6-Methylandenosine-Related lncRNAs in Tumor Microenvironment Are Potential Prognostic Biomarkers in Colon Cancer
por: Zhang, Hongliang, et al.
Publicado: (2021)

Screening of miRNAs as Prognostic Biomarkers for Colon Adenocarcinoma and Biological Function Analysis of Their Target Genes
por: Zheng, Guoliang, et al.
Publicado: (2021)

Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers
por: Cai, Yuan, et al.
Publicado: (2022)

Screening microRNAs as potential prognostic biomarkers for lung adenocarcinoma
por: Dai, Hongshuang, et al.
Publicado: (2023)

WASF2 Serves as a Potential Biomarker and Therapeutic Target in Ovarian Cancer: A Pan-Cancer Analysis
por: Yang, Xiaofeng, et al.
Publicado: (2022)

Machine Learning-Based Comparative Analysis of Pan-Cancer and Pan-Normal Tissues Identifies Pan-Cancer Tissue-Enriched circRNAs Related to Cancer Mutations as Potential Exosomal Biomarkers
por: Wang, Xuezhu, et al.
Publicado: (2021)

Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets
por: Zhang, Yinqi, et al.
Publicado: (2021)

Ipilimumab as a Cause of Severe Pan-Colitis and Colonic Perforation
por: Shah, Raj, et al.
Publicado: (2017)

Hook2 contributes to aggresome formation
por: Szebenyi, Györgyi, et al.
Publicado: (2007)

Caveolin-1 is an aggresome-inducing protein
por: Tiwari, Ajit, et al.
Publicado: (2016)

An inhibitor of ubiquitin conjugation and aggresome formation
por: An, Heeseon, et al.
Publicado: (2015)

Pan-cancer analysis reveals that G6PD is a prognostic biomarker and therapeutic target for a variety of cancers
por: Zeng, Tao, et al.
Publicado: (2023)

SRSF3 Expression Serves as a Potential Biomarker for Prognostic and Immune Response in Pan-Cancer
por: Li, Zihua, et al.
Publicado: (2022)

A pan-cancer analysis of ABI3BP: a potential biomarker for prognosis and immunoinfiltration
por: Feng, Yan, et al.
Publicado: (2023)

ISYNA1: An Immunomodulatory-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer
por: Jia, Zeming, et al.
Publicado: (2022)

NCOA4: An Immunomodulation-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer
por: Gu, Chenzheng, et al.
Publicado: (2022)

MARCH1 as a novel immune-related prognostic biomarker that shapes an inflamed tumor microenvironment in lung adenocarcinoma
por: Xu, Zhiyong, et al.
Publicado: (2022)

Autophagy-Induced HDAC6 Activity During Hypoxia Regulates Mitochondrial Energy Metabolism Through the β-Catenin/COUP-TFII Axis in Hepatocellular Carcinoma Cells
por: Yan, Xiaoyu, et al.
Publicado: (2021)

The Potential of panHER Inhibition in Cancer
por: Wang, Xiaochun, et al.
Publicado: (2015)

Targeting the integrated networks of aggresome formation, proteasome, and autophagy potentiates ER stress-mediated cell death in multiple myeloma cells
por: MORIYA, SHOTA, et al.
Publicado: (2014)

Integrated Analysis of Distant Metastasis-Associated Genes and Potential Drugs in Colon Adenocarcinoma
por: Wu, Miaowei, et al.
Publicado: (2020)

Potential Impact of ALKBH5 and YTHDF1 on Tumor Immunity in Colon Adenocarcinoma
por: Yan, Guanyu, et al.
Publicado: (2021)

Pan-Cancer Analysis of the Oncogenic and Immunological Role of RCN3: A Potential Biomarker for Prognosis and Immunotherapy
por: Ding, Jian, et al.
Publicado: (2022)

Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types
por: Hu, Ankang, et al.
Publicado: (2022)

Pan-cancer analysis identified OAS1 as a potential prognostic biomarker for multiple tumor types
por: Jiang, Shan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s0e1lream8u28ta474boa974ma